Company profilePharmaceutical#582 of 1,318 in Pakistan✓ No DRAP alerts

TREAD PHARMACEUTICALS PVT LTD

Pharmaceutical company · 20 brands · 17 molecules

Ranked #4 of 39 companies in Calcium Channel Blockers

20 registered products 14 pharmaceutical brands 17 distinct molecules 0 DRAP alerts

Company overview

20
registered products
14
pharmaceutical brands
17
distinct molecules
6
therapeutic classes
0
DRAP alerts

TREAD PHARMACEUTICALS PVT LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 20 product registrations across 17 distinct molecules. Its portfolio is concentrated in Calcium Channel Blockers and Cardiac Care. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by TREAD

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Nifedipine2 brands
Diclofenac1 brand
Calcium1 brand
Diltiazem1 brand
Amlodipine1 brand

Therapeutic classes

Calcium Channel Blockers · 3Cardiac Care · 2Lipid Modifying Agents · 1Antimycobacterials (Antituberculosis) · 1Diuretic · 1Angiotensin-Ii Antagonists, Combinations · 1

Conditions treated

Hypertension · 2

Price band (DRAP official ceilings)

Registered products priced by source
Servaid2 products · Rs 289.8 – Rs 329
Median across source: Rs 309.4

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Werrick Pharmaceuticals Pakistan holds 138 molecules not in this portfolio
AcetazolamideAlendronateAlprazolamAmlodipineAmoxicillinAmoxycillin
SEARLE PAKISTAN (PVT.) LTD. holds 238 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAminophyllineAmitriptyline
Atco Pharma International (Pvt) Ltd holds 232 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline

Get the full profile for TREAD

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.